BIOMAT Database Logo BIOMAT Database Logo

Alpha-interferon structure and natural killer cell stimulatory activity. 1990

B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Department of Molecular Genetics, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway 08854.

Expression vectors for human alpha-interferon (Hu-IFN-alpha) J1, a site-specific mutant [Ser116]Hu-IFN-alpha J1, and Hu-IFN-alpha J/C or Hu-IFN-alpha C/J hybrids were constructed and expressed in Escherichia coli. These interferons and others were purified by immunoaffinity chromatography with a monoclonal antibody against human alpha-interferon. Their antiviral activity and ability to stimulate natural killer cell activity were determined in comparison to several other human interferons. These results provide some insight into structure-activity relationships for stimulating natural killer cells and confirm our previous conclusions that antiviral activity cannot be used to predict other activities for an individual IFN-alpha species. The observations suggest that the tertiary structure rather than any specific linear sequence of amino acids regulates the ability of the interferons to stimulate natural killer cell activity.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Interferon modulation of natural killer cell activity.
January 1980, Annals of the New York Academy of Sciences,
B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
September 1983, Annals of neurology,
B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Alpha interferon treatment in myasthenia gravis: effects on natural killer cell activity.
March 1998, Journal of neuroimmunology,
B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Depression of natural killer cell activity by interferon.
December 1981, The Journal of infectious diseases,
B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Pulmonary compartmentalization of interferon and natural killer cell activity.
November 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Modulation of natural killer activity by thymosin alpha 1 and interferon.
January 1985, Cancer immunology, immunotherapy : CII,
B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Recombinant gamma interferon enhances natural killer cell activity similar to natural gamma interferon.
March 1983, Biochemical and biophysical research communications,
B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha.
August 1982, International journal of cancer,
B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Augmentation of mouse natural killer cell activity by interferon and interferon inducers.
January 1979, Journal of immunology (Baltimore, Md. : 1950),
B L Li, and X X Zhao, and X Y Liu, and H S Kim, and K Raska, and J R Ortaldo, and B Schwartz, and S Pestka
Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-alpha 2.
November 1985, Clinical immunology and immunopathology,
Copied contents to your clipboard!